自披露获得全球领先医疗影像软件公司Pro Medicus（ASX股票代码:PME）1000万澳元战略投资以来，4DMedical Ltd (ASX股票代码:4DX) 股价持续飙升，周四再度飙涨20.25%，近一周涨幅扩升至97.92%。

4DX最新价0.475澳元，已发行股本4.66亿股，市值2.21亿澳元。

呼吸影像技术公司4DMedical (ASX:4DX)近日宣布Pro Medicus将以混合式债务股权贷款的方式向公司提供1000万澳元资金支持，用于加速现有产品商业推广及算法肺成像工具CT:VQ在美国的监管批准。

4DX董事总经理/首席执行官兼创始人Andreas Fouras表示，预计CT:VQ获得FDA批准的时间将会缩短，考虑到近期积极的运营势头，“我们将在未来几个月取得非常强劲的表现。”

截止上季度末4DX账面现金结余688万澳元。

（图片来源：4DX公告）

（图片来源：4DX公告）

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.